Healthcare / Medical - PharmaceuticalsUpdated 2026-05-10 22:07 UTC

LON/0R2M stock hub

LON/0R2M has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

LON/0R2Mis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

53.4B

London Stock Exchange

Market data

Live price

Current market quote for this ticker.

Current price

LON/0R2M

In the news

Latest news · LON/0R2M

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E13.7

P25 12.9P50 16.9P75 23.5

Trailing P/E15.9

P25 15.9P50 22.9P75 35.8

ROE14.5

P25 -54.2P50 2.1P75 13.7

ROIC12.9

P25 -38.1P50 3.3P75 11.9

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All LON/0R2M market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

228

Groups with data

Currency

USD

Showing 228 of 228 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	UK
Employees	15,343
Employees Change	304%
Employees Change Percent	2.01
Enterprise value	$41.8B
Exchange	London Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Medical - Pharmaceuticals
Isin	US75886F1075
Last refreshed	2026-05-10
Market cap	$53.4B
Price	$715
Price currency	USD
Rev Per Employee	736,406.68x
Sector	Healthcare
Sic	2834
Symbol	lon/0R2M
Website	https://www.regeneron.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	6.28%
EV Earnings	12.47x
EV/EBIT	14.81x
EV/EBITDA	12.88x
EV/FCF	13.41x
EV/Sales	3.81x
FCF yield	5.84%
Forward P/E	13.74x
P/B ratio	2.24x
P/E ratio	15.93x
P/S ratio	4.72x
PE Ratio10 Y	22.18x
PE Ratio3 Y	19.49x
PE Ratio5 Y	16.67x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	25.76%
EBITDA Margin	29.38%
FCF margin	27.57%
Gross margin	43.89%
Gross Profit	$5B
Gross Profit Growth	-4.75%
Gross Profit Growth Q	12.57%
Gross Profit Growth3 Y	-1.77%
Gross Profit Growth5 Y	5.15%
Net Income	$3.3B
Net Income Growth	-1.69%
Net Income Growth Q	-10.08%
Net Income Growth Years	2%
Net Income Growth3 Y	1.88%
Net Income Growth5 Y	2.01%
Pretax Margin	34.56%
Profit Margin	29.65%
Profit Per Employee	$218,332
Profitable Years	14
ROA	6.13
Roa5y	11.91
ROCE	10.75
ROE	14.55
Roe5y	24.44
ROIC	12.93
Roic5y	28.16

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	28.75%
Cagr3y	-1.81%
Cagr5y	7.82%
EPS Growth	4.14
EPS Growth Q	-7.15
EPS Growth Years	2
EPS Growth3 Y	3.75
EPS Growth5 Y	3.17
FCF Growth	32.6%
FCF Growth Q	3.98%
FCF Growth3 Y	4.02%
FCF Growth5 Y	15.18%
OCF Growth	26.8%
OCF Growth Q	3.23%
OCF Growth10 Y	12.99%
OCF Growth3 Y	5.4%
OCF Growth5 Y	14.13%
Revenue Growth	5.92x
Revenue Growth Q	19.04x
Revenue Growth Quarters	4x
Revenue Growth Years	3x
Revenue Growth3 Y	6.45x
Revenue Growth5 Y	10.16x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.38
Assets	$31B
Cash	$6.6B
Current Assets	$13.4B
Current Liabilities	$3.7B
Debt	$2B
Debt EBITDA	$0.61
Debt Equity	$0.09
Debt FCF	$0.66
Equity	$23.8B
Interest Coverage	80.06
Liabilities	$7.2B
Long Term Assets	$17.6B
Long Term Liabilities	$3.4B
Net Cash	$12B
Net Cash By Market Cap	$22.46
Net Cash Growth	6.12%
Net Debt EBITDA	$-3.61
Net Debt Equity	$-0.5
Net Debt FCF	$-3.85
Tangible Book Value	$22.8B
Tangible Book Value Per Share	$224
WACC	5.72

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	3.57
Inventory Turnover	2.66
Net Working Capital	$3.8B
Quick ratio	2.84
Working Capital	$9.9B
Working Capital Turnover	$0.83

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	5.61%
Dividend Growth	0%
Dividend Growth Years	1%
Dividend per share	$2.68
Dividend Years	2
Dividend Yield	0.37%
Ex Div Date	2026-02-20
Last Dividend	$0.7
Payout Frequency	Quarterly
Payout Ratio	8.61%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	28.73%
200-day SMA	685.3
3Y total return	-5.33%
50-day SMA	748
50-day SMA vs 200-day SMA	50over200
5Y total return	45.67%
All Time High	1,210.9
All Time High Change	-40.97%
All Time High Date	2024-08-27
All Time Low	274.1
All Time Low Change	160.74%
All Time Low Date	2019-10-03
ATR	36.06
Beta	0.3
Ch YTD	-7.66
High	740.9
High52	820
High52 Date	2026-01-12
High52ch	-12.83%
Low	700.1
Low52	477
Low52 Date	2025-06-05
Low52ch	49.84%
Ma50ch	-4.44%
Price vs 200-day SMA	4.3%
RSI	44.69
RSI Monthly	49.07
RSI Weekly	48.79
Sharpe ratio	0.54x
Sortino ratio	0.87
Total Return	5.98%
Tr YTD	-7.54
Tr1m	-5.89%
Tr1w	1.63%
Tr3m	-8.38%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$2.9B
Operating Income Growth	-3.33
Operating Income Growth Q	23.31
Operating Income Growth3 Y	-6.56
Operating Income Growth5 Y	-0.75
Operating margin	25.76

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	97,672,229%
Shares Insiders	3.83%
Shares Institutions	89.51%
Shares Qo Q	0.19%
Shares Yo Y	-5.61%
Short Ratio	4.14

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$2.4B
Average Volume	438.15x
Bv Per Share	233.5
CAPEX	$-681.3M
Ch1m	-5.89
Ch1w	1.63
Ch1y	28.03
Ch3m	-8.49
Ch3y	-5.97
Ch5y	44.69
Ch6m	10.18
Change	0.7%
Change From Open	0.39
Close	709.8
Days Gap	0.31
Depreciation Amortization	396,097,560
Dollar Volume	67,188.4
Earnings Date	2026-04-29
EBIT	$2.9B
EBITDA	$3.3B
EPS	$31.1
F Score	4
FCF	$3.1B
FCF EV Yield	7.46x
Financing CF	-2,596,344,462
Fiscal Year End	December
Founded	1,988
Graham Number	567.12997
Graham Upside	-20.66
Income Tax	$555.5M
Investing CF	-1,291,583,678
Is Primary Listing	0
Last Earnings Date	2026-04-29
Last Report Date	2026-03-31
Lynch Fair Value	$224
Lynch Upside	-68.62
Ma150	723.8
Ma150ch	-1.25%
Ma20	730.7
Ma20ch	-2.17%
Net CF	-92,694,132
Open	712
P FCF Ratio	17.14
P OCF Ratio	14.06
Payment Date	2026-03-05
Position In Range	35.91
Ppne	3,862,758,075.4
Price Date	2026-05-08
Price EBITDA	$16.08
Ptbv Ratio	2.34
Relative Volume	0.22x
Revenue	11,298,687,678x
SBC By Revenue	6.67x
Share Based Comp	753,821,397
Tax By Revenue	4.92x
Tax Rate	14.22%
Tr6m	10.45%
Volume	94
Z Score	6.53

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

LON/0R2M dividend yield, growth & safety

Yield, payout sustainability, and the multi-year growth streak.

Dividend yield

+0.4%

$2.68 annual per share

Payout ratio

+8.6%

Share of earnings returned as dividends. Below 60% is generally sustainable.

5Y dividend CAGR

n/a

1 consecutive years of growth

Total shareholder yield

+6.0%

Next ex-dividend date: 2026-02-20

Performance

LON/0R2M stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns LON/0R2M?

Insider, institutional, and short-interest positioning.

Institutional ownership

+89.5%

Share of float held by funds and institutions

Insider ownership

+3.8%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

LON/0R2M momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

44.7

Neutral momentum band

Price vs 200-day MA

+4.3%

50/200-day relationship not available

Beta (5Y)

0.30

Less volatile than the market

Sharpe ratio

0.54

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About LON/0R2M

Hub-level FAQ points readers to the deeper analysis pages.

What is the current lon/0R2M stock rating?

lon/0R2M is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full lon/0R2M analysis?

The full report lives at /stocks/lon/0R2M/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for lon/0R2M?

The latest report frames lon/0R2M around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the lon/0R2M page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.